AJM online
Clinical communication to the editor
Heparin-induced Thrombocytopenia in Patients Receiving Plasma Exchange

https://doi.org/10.1016/j.amjmed.2014.08.004Get rights and content

Section snippets

Discussion

As is typical of heparin-induced thrombocytopenia Type 2, both patients developed thrombocytopenia between days 4 and 14 after initiation of heparin therapy.1 Patients received unfractionated heparin for deep vein thrombosis prophylaxis and for catheter flushes during plasmapheresis. The fact that thrombocytopenia developed after beginning plasmapheresis in both cases indicates that the heparin used for flushes has likely contributed to the heparin-induced thrombocytopenia, though subcutaneous

References (2)

Cited by (0)

Funding: None.

Conflicts of Interest: None.

Authorship: All authors had access to the data and a role in writing this manuscript.

View full text